Search

everythinglearnresearchcommunity

for

Search:↓

Acne in adult women is common and requires thorough evaluation and treatment due to its impact on self-esteem.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

Follicular mucinosis in a 15-year-old is usually harmless but needs monitoring for possible lymphoma.

Psoriasis is a common skin disorder caused by immune system issues, treatable with various therapies.

JAK inhibitors show promise in treating difficult skin diseases.

Generalized glucocorticoid resistance causes hormone imbalances and varied symptoms due to gene mutations.

Rosemary may help brain health and reduce inflammation.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Microneedling radiofrequency improves skin texture and tone by stimulating collagen and elastin.

Anti-Ku antibodies are linked to unique symptoms and may involve autophagy issues.

Alopecia X in dogs is a cosmetic issue, not a hormonal disorder, and harmful treatments should be avoided.

Antimicrobial therapy can help manage Folliculitis Decalvans.

Mechanical stress may cause lesions in Hidradenitis suppurativa.

Hormonal treatments can effectively improve hidradenitis suppurativa symptoms.

More inflammation leads to faster and worse hair loss in women with frontal fibrosing alopecia.

Homeopathic treatment may help manage alopecia areata effectively.

Minoxidil is an effective and safe treatment for common hair loss when applied to the skin, but more research is needed for optimal use.

Cicatricial alopecia causes permanent hair loss and is treated to relieve symptoms and stop progression.

The gel with apocynin-loaded nanoparticles shows promise for treating rheumatoid arthritis.

Runners often face skin problems like blisters and infections, and both prevention and early treatment are important.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

More skin issues appeared in the emergency department during COVID-19, highlighting the need for better dermatology training and resources.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

17β-estradiol can reduce inflammation in the skin.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Neuropeptides affect skin inflammation, repair, and hair growth, with potential for therapy.

Nanocapsules can improve clobetasol delivery to hair follicles, reducing side effects.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

PRP and ADSC therapies show promise in improving symptoms of genital lichen sclerosus with minimal side effects.